You are currently viewing a new version of our website. To view the old version click .

Medical Sciences Forum

Medical Sciences Forum is an open access journal dedicated to publishing findings resulting from academic conferences, workshops and similar events in all areas of medical sciences, for advances in basic, translational and clinical research and related disciplines.
The conference organizers and proceedings editors are responsible for managing the peer-review process and selecting papers for conference proceedings.

All Articles (808)

  • Proceeding Paper
  • Open Access

This research compares the Mediterranean and Japanese diets and considers diet as associated with anti-ageing as well as leading a long and healthy life. Since Mediterranean countries, including Italy and Greece, have one-third the mortality ratio with respect to cardiovascular diseases compared to America and northern Europe, the Mediterranean diet is regarded as healthy. Here, the research shows the reasons why Mediterranean and Japanese diets have these properties. Both the Mediterranean and Japanese diets are typically low in fat, sugar, and calories, and are characterised by a high intake of vegetables, legumes, fish, and cereals. Differences include a greater consumption of polyphenol-rich extra virgin olive oil, dairy products, and a lower amount of meat consumption in the Mediterranean diet, as well as less use of fat; there is an abundant consumption of fermented foods and seaweed in the Japanese diet. Japan’s globally leading long life expectancy is partly attributed to the cultural concept of “ME-BYO,” which emphasises recognising and managing non-disease conditions before they develop into clinical illness. This tendency may be one of the reasons for the long lifespan of Japanese people.

12 December 2025

PRISMA flowchart of the systematic review: the Mediterranean diet.
  • Conference Report
  • Open Access

Mattias Collin 1, Berit Olofsson 1, Andreas Naegeli 2 and Pontus Nordenfelt 1 [...]

12 December 2025

  • Proceeding Paper
  • Open Access

Antibody–drug conjugates (ADCs) represent a novel and rapidly evolving class of targeted therapeutics that combine the high specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. These engineered molecules are designed to selectively deliver cytotoxic agents to specific cells, thereby reducing off-target toxicity and enhancing therapeutic efficacy. In oncology, ADCs have already demonstrated significant clinical success, particularly in the treatment of hematological malignancies and solid tumors. Agents such as trastuzumab emtansine and brentuximab vedotin exemplify how ADCs can effectively target cancer cells while limiting damage to healthy tissues. This review comprehensively explores the key aspects of the use of ADCs in autoimmune disorders, which is an evolving field in immunotherapy.

11 December 2025

  • Proceeding Paper
  • Open Access

Radiolabeled monoclonal antibodies represent a promising approach to integrate molecular imaging with immunotherapy for cancer diagnosis and treatment. These antibodies target immune checkpoints and tumor-associated antigens, enabling non-invasive visualization of tumor dynamics through PET and SPECT imaging. Evidence from preclinical and clinical studies suggests that such imaging can provide insights into antibody distribution, immune cell infiltration, and potential treatment responses within the tumor microenvironment. By combining diagnostic and therapeutic capabilities, antibody-based theranostics offer opportunities for personalized treatment planning and understanding mechanisms of resistance. This review highlights current advances in antibody-based molecular imaging, discusses challenges in translation, and explores future directions for integrating imaging with immuno-oncology strategies to improve patient outcomes. Radiolabeled antibodies allow non-invasive assessment of tumor–immune interactions, supporting adaptive treatment planning and bridging immunotherapy with molecular imaging.

26 November 2025

News & Conferences

Issues

Open for Submission

Editor's Choice

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Med. Sci. Forum - ISSN 2673-9992